Department of Medicine, Diagnostic and Interventional Endoscopy of the Pancreas, The Pancreas Institute, University Hospital of Verona, Verona, Italy.
Department Medical and Surgical Sciences, University of Foggia, Foggia, Italy.
Expert Rev Gastroenterol Hepatol. 2024 Sep;18(9):551-559. doi: 10.1080/17474124.2024.2399176. Epub 2024 Sep 2.
Same-session endoscopic ultrasound (EUS) and endoscopic retrograde cholangiopancreatography (ERCP) is an attractive policy for patients with distal malignant biliary obstruction (DMBO) requiring fine-needle biopsy (FNB) and biliary drainage. However, scanty and conflicting data exists regarding safety and efficacy when comparing these two procedures performed in same versus separate sessions.
Single-center, retrospective, propensity score-matched study including patients with DMBO who underwent EUS-FNB followed by ERCP during the same or separate sessions. The primary outcome was the safety of the procedure [number of patients experiencing adverse events (AEs), overall AEs, its severity, post-ERCP pancreatitis (PEP)]. Secondary outcomes were successful ERCP, use of advanced cannulation techniques, EUS-FNB adequacy, length of hospital stay, overall procedure time, and time to recurrent biliary obstruction.
After propensity matching, 87 patients were allocated to each group. AEs developed in 23 (26.4%) vs. 17 (19.5%) patients in the same and separate sessions group, respectively ( = 0.280). The overall number, the severity of AEs, and the rate of PEP were similar in the two groups. Secondary outcome parameters were also comparable in the 2 groups.
Same-session EUS-FNB followed by ERCP with biliary drainage is safe and does not impair technical outcomes of tissue adequacy and biliary cannulation.
对于需要进行细针活检(FNB)和胆道引流的远端恶性胆道梗阻(DMBO)患者,同一次内镜超声(EUS)和内镜逆行胰胆管造影(ERCP)是一种有吸引力的治疗策略。然而,当比较在同一次或不同次进行的这两种程序时,关于安全性和有效性的数据很少且存在冲突。
这是一项单中心、回顾性、倾向评分匹配研究,纳入了接受 EUS-FNB 后行 ERCP 的 DMBO 患者,这些操作是在同一次或不同次进行的。主要结局是该程序的安全性[发生不良事件(AEs)的患者数量、总体 AEs、其严重程度、ERCP 后胰腺炎(PEP)]。次要结局包括 ERCP 成功、使用先进的插管技术、EUS-FNB 充分性、住院时间、总手术时间和复发性胆道梗阻时间。
在进行倾向评分匹配后,每组 87 例患者。同次和分次组分别有 23(26.4%)和 17(19.5%)例患者发生 AEs( = 0.280)。两组的总体 AEs 数量、严重程度和 PEP 发生率相似。两组的次要结局参数也相似。
EUS-FNB 后同次行 ERCP 胆道引流是安全的,不会影响组织充分性和胆道插管的技术结局。